OBI Pharma Updates on Clinical Trial Activities During COVID-19 Pandemic
TAIPEI, TAIWAN. APRIL 8, 2020– OBI Pharma has been closely monitoring the impact of the COVID-19 pandemic worldwide. We realize the intense challenges that patients and our clinical research investigators …
Due to the tense situation of Novel Coronavirus Disease (COVID-19), company decided to pause the recruitment of Global Phase III clinical study for 3 months and will restart recruitment when epidemic gets controlled.
Date of occurrence of the event: Apr 06, 2020 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head Office Reciprocal shareholding ratios: No …
Updates on company’s negotiable securities for investors’ information
1.Date of occurrence of the event: Mar 23, 2020 2.Cause of occurrence: Notified by Taipei Exchange (TPEx) to release information 3.Financial and business information: (1 ) Latest 1 month SUBJECT …
Announcement on change of accountant due to internal adjustment of accounting firm
Date of occurrence of the event: Mar 13, 2020 Name of the original accounting firm and name of the original CPA: PwC Taiwan, Yu-Kuan Lin; PwC Taiwan, Sheng-Wei Deng Name …
The Board of Directors resolved to hold 2020 Annual General Meeting
Date of the board of directors resolution: Mar 13, 2020 Date for convening the shareholders’ meeting: Jun 22, 2020 Location for convening the shareholders’ meeting: Masterlink Securities Education and Training …
The board of directors have resolved not to distribute dividends for 2019
Date of the board of directors resolution: Mar 13, 2020 Year or quarter which dividends belong to : 2019 Period which dividends belong to: Jan 01, 2019 to Dec 31, …
Board of Directors approved the Company’s 2019 financial statement
Date of occurrence of the event: Mar 13, 2020 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: Not …
Clarification on News Article by Economy Daily News
Date of occurrence of the event: Mar 12, 2020 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: Not …
OBI Pharma Inc. to attend Investor Conference hosted by Masterlink Securities
1.Date of the event: Mar 11, 2020 2.Time: 14:30:00 NST 3.Location: Taipei New Horizon (Address: 6F., No. 88, Yanchang Rd., Xinyi Dist., Taipei City 110, Taiwan) 4.Summary: OBI Pharma Inc. …
OBI Pharma Granted U.S. FDA Orphan Drug Designation for the Treatment of Gastric Cancer for Its Antibody-Drug Conjugate (ADC) Targeted Cancer Therapy, OBI-999
Second Orphan Drug Designation for OBI-999, a novel first-in-class Antibody-Drug Conjugate in combination with a validated payload (MMAE) and the antibody targeting Globo H, a glycolipid antigen found on multiple …